Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe scalp psoriasis: Efficacy and safety results through week 16 in a phase 3b/4, multicenter, randomized, double-blinded, placebo-controlled trial (PSORIATYK SCALP).
Journal: JAAD international
Published: September 28, 2025
Impact of deucravacitinib on NLR and other inflammatory biomarkers of cardiovascular risk in psoriasis: Posthoc analyses of phase 3 trials.
Journal: The Journal of investigative dermatology
Published: September 22, 2025
The Role of Early Subspeciality Consultation in the Timing of Hemophagocytic Lymphohistiocytosis Diagnosis and Management.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: July 15, 2021
Thrombotic vasculopathy due to polymer coating emboli after an endovascular procedure.
Journal: JAAD case reports
Published: May 05, 2021
Spectrum of PD-1 and PD-L1 inhibitor cutaneous adverse events in skin of color: a retrospective, single-institutional study in an urban community.
Journal: Acta oncologica (Stockholm, Sweden)
Published: February 01, 2021
Unilateral perniosis (chilblains) following hip arthroplasty.
Journal: JAAD case reports
Published: January 11, 2021
Drug-induced cutaneous vasculitis and anticoagulant-related cutaneous adverse reactions: insights in pathogenesis, clinical presentation, and treatment.
Journal: Clinics in dermatology
Published: December 20, 2020
Last Updated: 09/26/2026